This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kilhamn, J.
Right arrow Articles by Jertborn, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kilhamn, J.
Right arrow Articles by Jertborn, M.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, May 2003, p. 426-430, Vol. 10, No. 3
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.3.426-430.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

T- and B-Cell Immune Responses of Patients Who Had Undergone Colectomies to Oral Administration of Salmonella enterica Serovar Typhi Ty21a Vaccine

Jan Kilhamn,1,2* Samuel B. Lundin,1 Hans Brevinge,3 Ann-Mari Svennerholm,1 and Marianne Jertborn1,2

Department of Medical Microbiology and Immunology and Göteborg University Vaccine Research Institute—GUVAX,1 Department of Infectious Diseases,2 Department of Surgery, Sahlgrenska University Hospital, Göteborg University, Göteborg, Sweden3

Received 19 September 2002/ Returned for modification 21 November 2002/ Accepted 4 March 2003

The capacity of an oral live attenuated Salmonella enterica serovar Typhi Ty21a vaccine to induce immune responses in patients who had undergone colectomies because of ulcerative colitis was evaluated, and these responses were compared with those of healthy volunteers. Purified CD4+ and CD8+ T cells from peripheral blood were stimulated in vitro by using the heat-killed Ty21a vaccine strain, and the proliferation and gamma interferon (IFN-{gamma}) production were measured before and 7 or 8 days after vaccination. Salmonella-specific immunoglobulin A (IgA) and IgG antibody responses in serum along with IgA antibody responses in ileostomy fluids from the patients who had undergone colectomies were also evaluated. Three doses of vaccine given 2 days apart failed to induce proliferative T-cell responses in all the six patients who had undergone colectomies, and increases in IFN-{gamma} production were found only among the CD8+ cells from three of the patients. In contrast, both proliferative responses and increased IFN-{gamma} production were observed among CD4+ and CD8+ T cells from 3 and 6 of 10 healthy volunteers, respectively. Salmonella-specific IgA and/or IgG antibody responses in serum were observed for five (56%) of nine patients who had undergone colectomies and in 15 (88%) of 17 healthy volunteers. In ileostomy fluids, significant anti-Salmonella IgA antibody titer increases were detected in six (67%) of nine patients who had undergone colectomies. The impaired T- and B-cell immune responses found after vaccination in the circulation of patients who have undergone colectomies may be explained by a diminished colonization of the Ty21a vaccine strain due to the lack of a terminal ileum and colon.

* Corresponding author. Mailing address: Department of Medical Microbiology and Immunology, Göteborg University, Box 435, SE-405 30 Göteborg, Sweden. Phone: 46-31-342 46 14. Fax: 46-31-82 69 76. E-mail: jan.kilhamn{at}medfak.gu.se.

Clinical and Diagnostic Laboratory Immunology, May 2003, p. 426-430, Vol. 10, No. 3
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.3.426-430.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»